Locus 109: LIPC (15q22.1)
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs2070895 |
| Chromosomal location | Chr15: 56,511,231 (15q22.1) |
| Gene (distance) | LIPC (-235) |
| Predicted causal gene | LIPC |
| Gene/protein classification | - |
| Metabolite (Pathway) | 1-palmitoylglycerophosphoethanolamine (Lysolipid; Lipid) |
| Biochemical locus-metabolite relationship | LIPC encodes hepatic lipase with activity against both triacylglycerols and phospholipids [6511790]. Hydrolysis of phospholipids generates lysolipids and fatty acids. |
| eQTL associations | LIPC (H) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | HDL cholesterol [18193044,20864672] |
| Known metabolite associations | Metabolite levels [23281178] |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL2127 |
| Drug information |
Compounds with no activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

